Overview

Vitamin C and Hiprex in rUTI

Status:
NOT_YET_RECRUITING

Trial end date:
2027-01-01

Target enrollment:

Participant gender:

Summary

A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

University Hospitals of North Midlands NHS Trust

Treatments:

Ascorbic Acid
methenamine hippurate